Clinical Report: Impact and Determinants of Early Ileostomy Closure in Rectal Cancer
Overview
This study evaluates the safety and efficacy of early ileostomy closure (EIC) at 2–4 weeks post-surgery in rectal cancer patients. Findings indicate that EIC is associated with lower stoma-related complications and improved quality of life compared to routine closure.
Background
Colorectal cancer is a prevalent malignancy, with rectal cancer accounting for a significant proportion of cases. Preventive ileostomy is commonly performed to mitigate complications such as anastomotic leakage, but the optimal timing for closure remains debated. Understanding the factors influencing early closure can enhance patient outcomes and guide clinical decision-making.
Data Highlights
Group
Post-Closure Complications
Stoma-Related Complications
Operative Time
SF-36 Quality of Life Score
Early Closure (EC)
No significant difference
Lower
Shorter
Higher
Routine Closure (RC)
No significant difference
Higher
Longer
Lower
Key Findings
Early ileostomy closure (EIC) at 2–4 weeks is safe and feasible for selected patients.
Patients undergoing EIC experienced significantly lower stoma-related complications compared to those with routine closure.
Operative time was shorter in the EIC group.
The quality of life, as measured by the SF-36, was significantly higher in the EIC group.
Age, tumor site, neoadjuvant chemoradiotherapy, and pTNM stage were identified as independent factors influencing the decision for EIC.
Clinical Implications
Clinicians should consider early ileostomy closure for selected rectal cancer patients to reduce stoma-related complications and improve quality of life. The established nomogram can aid in preoperative stratification and personalized treatment planning.
Conclusion
Early ileostomy closure presents a viable option for select rectal cancer patients, offering benefits in terms of complications and quality of life. Further research is warranted to refine patient selection criteria.
